Who founded Congruencetx?

Congruencetx was founded by Clarissa Desjardins in 2021.

Who are Congruencetx's investors?

Congruencetx's investors include OrbiMed, Alexandria, DIMENSION, BDC Thrive Venture Fund for Women, Lumira Ventures.

Congruencetx

Founded 2021 · 43 employees on LinkedIn · 5 known investors

Congruence is a drug discovery company that applies protein dynamics, biophysics, machine learning, and computational chemistry to model proteins in their full dynamic state and predict disease correction in silico. It uses these computational methods to identify and design therapeutics.

AI & Machine Learning Biotech Deep Tech

Founders & leadership

Congruencetx was founded in 2021 by Clarissa Desjardins.

Clarissa DesjardinsinFounder

Investors · 5

OrbiMed✓ verifiedNew York · $1M – $75M

Alexandria✓ verifiedPasadena

DIMENSION✓ verifiedTokyo

BDC Thrive Venture Fund for WomenMontréal

Lumira VenturesToronto · $1M – $10M

Competitors · 1

by search overlap

Bioworld4 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.

Companies competing with Congruencetx for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Venture funding drops in Seattle area as AI boom reshapes startup world – GeekWiregeekwire.com · Jul 2026

Seeds | Jumps to World Model Unicorn in One Year! Manifold AI Raises Hundreds of Millions in New Funding | Gasgooautonews.gasgoo.com · Jun 2026

Fei-Fei Li's World Labs Raises $1B in Fresh Funding to Advance Development of World Modelstheaiinsider.tech · Feb 2026

Frequently asked questions

What does Congruencetx do?: Congruence is a drug discovery company that applies protein dynamics, biophysics, machine learning, and computational chemistry to model proteins in their full dynamic state and predict disease correction in silico. It uses these computational methods to identify and design therapeutics.
Who founded Congruencetx?: Congruencetx was founded by Clarissa Desjardins in 2021.
Who are Congruencetx's investors?: Congruencetx's investors include OrbiMed, Alexandria, DIMENSION, BDC Thrive Venture Fund for Women, Lumira Ventures.